US Patent 11077114 Stabilized formulations of CNS compounds
Patent 11077114 was granted and assigned to Supernus Pharmaceuticals, Inc. on August, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11077114 Stabilized formulations of CNS compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
